ArticlePulmonary medicine2026
Determinants of Bronchiectasis Among Patients Attending Chest Clinic of Teaching Hospital in Ethiopia: Case-Control Study.
Article in Pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Determinants of Bronchiectasis Among Patients Attending Chest Clinic of Teaching Hospital in Ethiopia: Case-Control Study.Pulmonary medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBronchiectasis is a chronic lung disease characterized by cough and purulent sputum, recurrent infections, and airway damage. It affects people of all ages and is associated with considerable morbidity and mortality. OBJECTIVES AND
methodsA case-control study was conducted to assess factors associated with bronchiectasis. Each patient with HRCT-confirmed bronchiectasis who visited the chest clinic was selected as a case, whereas age- and sex-matched patients without bronchiectasis were selected as controls. Data was collected using a chart review and questionnaire from April 1, 2022, to June 30, 2022. Then, data was entered and analyzed using SPSS Version 25. Frequencies and cross-tabulations were used to summarize descriptive statistics of the data. Chi-square tests and logistic regression were done to establish associations for variables.
resultsThe study included 77 cases and 153 controls, with 49.35% of the cases and 33.99% of the controls being between the ages of 41 and 60. After adjusting for potential confounders, a multivariable logistic regression analysis showed that four variables were independent predictors of bronchiectasis. Bronchiectasis was six times more likely to occur in patients with a history of pulmonary tuberculosis (AOR = 6.182; 95% CI (3.16-12.10), p < 0.001). COPD (AOR = 2.896; 95% CI = 1.460-5.746, p = 0.002), bronchial asthma (AOR = 2.124; 95% CI = 1.086-4.154, p = 0.028), and COVID-19 (AOR = 2.786; 95% CI = 1.454-5.340, p = 0.002) also increased the risk of bronchiectasis by more than twofold. There was no significant association between bronchiectasis and age, sex, or smoking history. CONCLUSION AND RECOMMENDATIONS: Pulmonary tuberculosis, COVID-19, chronic obstructive pulmonary disease, and bronchial asthma are associated with the development of bronchiectasis. Attention should be given to early identification of bronchiectasis among patients with these lung diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.